Allied Healthcare Products (AHPI) Competitors

AHPI vs. NOVN, NOVNQ, HGEN, GNCA, HTGMQ, KLDO, IGNY, STAB, SIENQ, and BBLG

Should you be buying Allied Healthcare Products stock or one of its competitors? The main competitors of Allied Healthcare Products include Novan (NOVN), NVN Liquidation (NOVNQ), Humanigen (HGEN), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), Kaleido Biosciences (KLDO), Ignyte Acquisition (IGNY), Statera Biopharma (STAB), Sientra (SIENQ), and Bone Biologics (BBLG). These companies are all part of the "medical" sector.

Allied Healthcare Products vs.

Novan (NASDAQ:NOVN) and Allied Healthcare Products (NASDAQ:AHPI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking.

Allied Healthcare Products has higher revenue and earnings than Novan. Novan is trading at a lower price-to-earnings ratio than Allied Healthcare Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novan$24.71M0.00-$31.31M-$1.320.00
Allied Healthcare Products$27.05M0.00-$5.36M-$1.34N/A

Novan has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500. Comparatively, Allied Healthcare Products has a beta of -2.39, suggesting that its stock price is 339% less volatile than the S&P 500.

14.5% of Novan shares are owned by institutional investors. Comparatively, 4.2% of Allied Healthcare Products shares are owned by institutional investors. 1.3% of Novan shares are owned by insiders. Comparatively, 5.1% of Allied Healthcare Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Allied Healthcare Products has a net margin of 0.00% compared to Allied Healthcare Products' net margin of -128.61%. Novan's return on equity of 0.00% beat Allied Healthcare Products' return on equity.

Company Net Margins Return on Equity Return on Assets
Novan-128.61% -700.28% -39.58%
Allied Healthcare Products N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novan
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Allied Healthcare Products
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Novan and Novan both had 1 articles in the media. Allied Healthcare Products' average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Novan
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Allied Healthcare Products
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Novan received 138 more outperform votes than Allied Healthcare Products when rated by MarketBeat users. Likewise, 56.37% of users gave Novan an outperform vote while only 38.85% of users gave Allied Healthcare Products an outperform vote.

CompanyUnderperformOutperform
NovanOutperform Votes
239
56.37%
Underperform Votes
185
43.63%
Allied Healthcare ProductsOutperform Votes
101
38.85%
Underperform Votes
159
61.15%

Summary

Novan and Allied Healthcare Products tied by winning 6 of the 12 factors compared between the two stocks.

Get Allied Healthcare Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for AHPI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHPI vs. The Competition

MetricAllied Healthcare ProductsSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$16,000.00$9.38B$4.87B$7.48B
Dividend YieldN/A1.39%2.97%3.96%
P/E Ratio0.0027.41271.5720.61
Price / SalesN/A60.252,374.5080.22
Price / CashN/A20.4046.0634.58
Price / BookN/A6.214.654.30
Net Income-$5.36M$186.74M$103.06M$213.92M

Allied Healthcare Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOVN
Novan
0 of 5 stars
$0.00
flat
N/AN/A$22,000.00$24.71M0.0090Analyst Report
NOVNQ
NVN Liquidation
0 of 5 stars
$0.00
flat
N/AN/A$22,000.00$23.68M0.0090
HGEN
Humanigen
0 of 5 stars
N/AN/A-95.8%$24,000.00$1.70M0.006Gap Up
GNCA
Genocea Biosciences
0 of 5 stars
N/AN/AN/A$6,000.00$1.91M0.0074Analyst Report
News Coverage
HTGMQ
HTG Molecular Diagnostics
0 of 5 stars
$0.00
flat
N/AN/A$6,000.00$6.37M0.0053
KLDO
Kaleido Biosciences
0 of 5 stars
N/AN/AN/A$4,000.00$1.10M0.0076News Coverage
Positive News
IGNY
Ignyte Acquisition
0 of 5 stars
$0.01
flat
N/AN/A$38,000.00N/A0.00N/A
STAB
Statera Biopharma
0 of 5 stars
$0.00
flat
N/A-97.0%$38,000.00$1.49M0.0046
SIENQ
Sientra
0 of 5 stars
$0.07
flat
N/AN/A$777,000.00$90.55M-0.01304
BBLG
Bone Biologics
0 of 5 stars
$1.60
flat
N/AN/A$848,000.00N/A-0.032

Related Companies and Tools

This page (NASDAQ:AHPI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners